Daniel Payne's profile photo

Daniel Payne

Washington, D.C., United States

Washington Correspondent at STAT

Washington Correspondent @STATnews daniel.payne (at) statnews (dot) com Signal: danielp.100 @POLITICO / @OleMiss alum

Articles

  • 1 day ago | statnews.com | John Wilkerson |Daniel Payne

    The Senate parliamentarian struck down several major health care measures in Republicans’ tax bill, including Medicaid changes that the GOP was counting on to help pay for President Trump’s tax cuts. The parliamentarian’s decision is a major challenge to Republicans’ plans to reap savings from the Medicaid program and could lead lawmakers to look for new savings across federal programs. It may make it more difficult for them to pass the bill ahead of Trump’s July 4 deadline.

  • 1 week ago | statnews.com | Daniel Payne |John Wilkerson

    WASHINGTON — The Senate returns next week with critical choices on Medicaid policies that could cost hospitals billions of dollars and lead to millions losing coverage. Hospitals are scrambling to control the damage. Last month, the House passed its version of the One Big Beautiful Bill, which would help pay for President Trump’s tax cuts with reductions in federal spending on Medicaid. Last week, the Senate Finance Committee unveiled its version, which includes steeper Medicaid cuts.

  • 2 weeks ago | statnews.com | Lizzy Lawrence |Matthew Herper |Isabella Cueto |Elizabeth Cooney |Andrew Joseph |Daniel Payne | +1 more

    For more than a half-century, the Centers for Disease Control and Prevention have relied on outside experts to guide the agency’s recommendations on how vaccines should be used to prevent the spread of infectious disease. That task will now fall to a panel that includes several individuals who’ve either been openly critical of vaccines or who have scant infectious disease expertise.

  • 2 weeks ago | statnews.com | Daniel Payne |Elaine Chen

    WASHINGTON — Executives at pharmaceutical companies have been bracing for more information from the Trump administration this week about how it planned to lower drug prices. That information has not yet arrived, despite the administration’s self-imposed deadline to disclose by Wednesday the target prices for drugs, part of its plan to ensure Americans would pay no more than the lowest price for drugs paid by peer nations. The task was to be carried out by health secretary Robert F.

  • 2 weeks ago | statnews.com | Daniel Payne |Isabella Cueto |Chelsea Cirruzzo

    The new agency at the center of health secretary Robert F. Kennedy Jr.’s agenda is hitting its first hurdle: Congress. The administration’s sweeping reorganization plan for the Department of Health and Human Services would shrink the National Institutes of Health and slash a litany of disease prevention programs while making the Administration for a Healthy America a new crown jewel of the agency, focused on chronic disease.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
585
DMs Open
Yes
Daniel Payne
Daniel Payne @_daniel_payne
12 Jun 25

New: The Trump administration is "demanding" pharma companies begin negotiating to lower drug prices https://t.co/N4SnfXKHhA

Daniel Payne
Daniel Payne @_daniel_payne
12 Jun 25

RT @JonathanWosen: Just hours after RFK Jr. announced a new CDC vaccine advisory panel, 7 (!!) of my @statnews colleagues put together thi…

Daniel Payne
Daniel Payne @_daniel_payne
11 Jun 25

In Trump's sweeping plan to lower drug prices, details remain elusive https://t.co/W62e0hqI4L